Cytovance Biologics: The Preferred CGMP Biologics CDMO

Cytovance® Biologics, a leading biopharmaceutical CDMO based in Oklahoma City, excels in the rapid and cost-effective development and manufacture of large molecule APIs from both mammalian cell culture and microbial fermentation such as monoclonal antibodies, fragment antibodies, bispecifics, enzymes, fusion proteins, vaccines and other biological products including plasmid DNA and cell-based therapeutics. Cytovance services support the entire product lifecycle including cell line development, cell banking, microbial strain development, process and analytical development, and process characterization.